Voltaren Gel (diclofenac sodium topical gel) 1%

Voltaren is a widely recognized brand for pain management, formulated with diclofenac sodium to treat joint pain and arthritis. It was originally developed by Ciba-Geigy, a Swiss pharmaceutical company that later merged with Sandoz to form Novartis. In recent years, the consumer healthcare portion of the brand has transitioned through major corporate restructuring.

Today, the brand is owned by Haleon, a major consumer healthcare company that was spun off from GSK (GlaxoSmithKline) in 2022. While the brand has Swiss roots, Haleon is headquartered in the United Kingdom. Manufacturing occurs in multiple locations globaly to serve different regional markets, including facilities in Europe and North America. In many markets, it is available both as an over-the-counter treatment and as a prescription-strength medication.